Bridgepoint continues build-out of ag biologicals portfolio; Stafford Capital Partners closes SIT X on $1.04 billion; Rohatyn ...

Bridgepoint is ramping up its fundraising ambitions, with plans to launch a new flagship vehicle later this year. The FTSE 250 private equity company, which floated in London in the summer of 2021, ...

Robert also spoke on a panel about the mid-market, which Bridgepoint invests in both in the US and Europe. “I think the big difference is the US is one country, one language, one legal system ...

Partners Carlos Sanz and Rupprecht Pranckh discuss how the London-headquartered firm has built up its specialization in biological inputs and farmer productivity since 2017.

Revenue: UK£428.1m (up 34% from FY 2023). Net income: UK£64.8m (down 8.3% from FY 2023). Profit margin: 15% (down from 22% in FY 2023). The decrease in margin was driven by higher expenses. EPS ...

LONDON, January 21, 2021: Prescient Healthcare Group (Prescient), a global product strategy advisory firm serving the pharmaceutical and biotech industries, announced today that Bridgepoint ...